192 related articles for article (PubMed ID: 15646654)
21. Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphoma.
Andersen NS; Donovan JW; Zuckerman A; Pedersen L; Geisler C; Gribben JG
Exp Hematol; 2002 Jul; 30(7):703-10. PubMed ID: 12135667
[TBL] [Abstract][Full Text] [Related]
22. A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
Kurita D; Takeuchi K; Kobayashi S; Hojo A; Uchino Y; Sakagami M; Ohtake S; Takahashi H; Miura K; Iriyama N; Sugitani M; Miyoshi H; Hatta Y; Ohshima K; Takei M
Virchows Arch; 2016 Oct; 469(4):471-6. PubMed ID: 27457074
[TBL] [Abstract][Full Text] [Related]
23. Nodal mantle cell lymphoma: a descriptive study from a tertiary care center in South India.
Roy A; Kar R; Basu D
Indian J Pathol Microbiol; 2013; 56(2):94-7. PubMed ID: 24056642
[TBL] [Abstract][Full Text] [Related]
24. Blastoid mantle cell lymphoma occurring in a patient in complete remission of chronic myelogenous leukemia.
Garzia M; Sora F; Teofili L; Di Mario A; Voso MT; Rumi C; La Rocca LM; Sica S; Zini G
Lab Hematol; 2007; 13(1):30-3. PubMed ID: 17353181
[TBL] [Abstract][Full Text] [Related]
25. Nucleolated variant of mantle cell lymphoma with leukemic manifestations mimicking prolymphocytic leukemia.
Wong KF; So CC; Chan JK
Am J Clin Pathol; 2002 Feb; 117(2):246-51. PubMed ID: 11865846
[TBL] [Abstract][Full Text] [Related]
26. Mantle cell lymphoma diagnosed by conjunctival salmon-pink lesion biopsy.
Matsuo T; Ichimura K; Kubonishi S
J Clin Exp Hematop; 2014; 54(2):143-7. PubMed ID: 25318947
[TBL] [Abstract][Full Text] [Related]
27. Mantle cell lymphoma, blastoid variant, diagnosed on the basis of cytomorphology and flow cytometric immunophenotyping of the lymph node aspirate and peripheral blood.
Lee MJ; Kee KH; Jeon HJ
J Korean Med Sci; 2002 Apr; 17(2):173-8. PubMed ID: 11961299
[TBL] [Abstract][Full Text] [Related]
28. Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma.
Kanellopoulos A; Koutsi K; Georgiou G; Ntalagiorgos T; Petevi K; Boutsikas G; Papageorgiou L; Gainaru G; Flevari P; Angelopoulou MK; Meletis J; Vassilakopoulos TP
Int J Hematol; 2014 Jun; 99(6):777-81. PubMed ID: 24668076
[TBL] [Abstract][Full Text] [Related]
29. Treatment of synchronous mantle cell lymphoma and small lymphocytic lymphoma with bendamustine and rituximab.
Kourelis TV; Kahl BS; Benn P; Delach JA; Bilgrami SF
Acta Haematol; 2011; 126(1):40-3. PubMed ID: 21430370
[TBL] [Abstract][Full Text] [Related]
30. Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly.
Sreedharanunni S; Sachdeva MU; Malhotra P; Ahluwalia J; Naseem S; Prakash G; Khadwal A; Sharma P; Kumar N; Varma N; Varma S; Das R
Hematology; 2015 Oct; 20(9):530-7. PubMed ID: 25760312
[TBL] [Abstract][Full Text] [Related]
31. A Push to Consider Mantle Cell Lymphoma in Adults with Leukemia/Lymphoma with Blastoid Morphology.
Arinze N; Omar N; Keruakous A; Kolhe R; Savage N
Hematol Rep; 2023 Oct; 15(4):592-596. PubMed ID: 37873796
[TBL] [Abstract][Full Text] [Related]
32. [Complete response by rituximab monotherapy in a patient with leukemic mantle cell lymphoma diagnosed by fluorescence in situ hybridization analysis].
Okagawa Y; Kuroda H; Ishikawa K; Yamada M; Hoki T; Abe T; Sakurai T; Fujii S; Maeda M; Fujita M; Jyomen W; Iyama S; Kato J
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1547-50. PubMed ID: 23064069
[TBL] [Abstract][Full Text] [Related]
33. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
[TBL] [Abstract][Full Text] [Related]
34. [Monoclonal gammopathy and primary colonic mantle cell lymphoma].
Mohamed G; Kochlef A; Gargouri D; Kilani A; Elloumi H; Ouakaa A; Belhadj N; Romani M; Kharrat J; Ghorbel A
Rev Med Interne; 2009 Mar; 30(3):279-81. PubMed ID: 18814941
[TBL] [Abstract][Full Text] [Related]
35. Intraperitoneal application of rituximab in refractory mantle cell lymphoma with massive ascites resulting in local and systemic response.
Crysandt M; Neumann B; Das M; Engelbertz V; Bendel M; Galm O; Osieka R; Jost E
Eur J Haematol; 2007 Dec; 79(6):546-9. PubMed ID: 17903214
[TBL] [Abstract][Full Text] [Related]
36. [Mantle cell lymphoma: clinicopathologic features and prognostic factors of 102 cases occurring in Chinese patients].
Ji H; Li GD; Li FY; Bai YQ; Chen Y; Yang MZ; Wang LJ; Tang Y; Zhang P; Xia T; Li C; Feng J; Zou ZK; Yixi JC
Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):730-5. PubMed ID: 18307875
[TBL] [Abstract][Full Text] [Related]
37. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
38. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: comparison with clinical response and patients outcome.
Goteri G; Olivieri A; Ranaldi R; Lucesole M; Filosa A; Capretti R; Pieramici T; Leoni P; Rubini C; Fabris G; Lo Muzio L
Int J Immunopathol Pharmacol; 2006; 19(2):421-31. PubMed ID: 16831308
[TBL] [Abstract][Full Text] [Related]
40. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
